Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Martin Hauer-Jensen

Univ of Arkansas for Med Scis, Department: Pharmacology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Tocol Pharmaceuticals, LLC

Disclosed Value
Listed Reason
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution

Investigator is one of the inventors of the Technology licensed to Tocol Pharmaceuticals, LLC. that will be used or evaluated by this study. Tocol Pharmaceuticals, LLC. and the Investigator have potential for financial gain based on the outcomes of this study.

Listed Research Project
The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction

PROJECT NARRATIVE In view of the ongoing threat of mass casualties due to radiological accidents or nuclear terrorism, this project aims to investigate the role of the thrombomodulin?protein C pathway, a molecular pathway that plays a central role in the proper function of vascular endothelium, in short- and long-term injury from exposure to radiation. A better understanding of this pathway will provide opportunities to develop safe treatments that reduce injury in critical organs and prolong survival, when administered after radiation exposure.

Filed on June 08, 2017.

Tell us what you know about Martin Hauer-Jensen's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Martin Hauer-Jensen Univ of Arkansas for Med Scis Conflict of Interest Tocol Pharmaceuticals, LLC $0 - $4,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page